TURKISH JOURNAL OF MEDICAL SCIENCES, vol.48, no.2, pp.354-360, 2018 (SCI-Expanded)
Background/aim: Micronucleus (MN) frequency is used as a biomarker of chromosomal damage, genome instability, and cancer risk. The aim of this study was to evaluate the diagnostic usefulness of MN frequency to differentiate between malignant and benign pleural effusion samples.